# Diagnostic Performance of Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio in Detecting Insulin Resistance Among Obese Children and Adolescents

**Authors:** Semra Bahar Akin

PMC · DOI: 10.7759/cureus.103072 · Cureus · 2026-02-05

## TL;DR

This study finds that the TG/HDL-C ratio can help detect insulin resistance in obese children and teens, with moderate accuracy that works for both genders and all stages of puberty.

## Contribution

The study establishes the TG/HDL-C ratio as a feasible and sex/puberty-independent marker for insulin resistance in obese pediatric populations.

## Key findings

- The TG/HDL-C ratio had a moderate diagnostic accuracy (AUC=0.601) for detecting insulin resistance.
- The optimal TG/HDL-C threshold for identifying insulin resistance was around 1.7.
- Diagnostic performance was consistent across sex and pubertal stages.

## Abstract

Background

We evaluated the diagnostic performance of the triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio for detecting insulin resistance (IR) in obese children and adolescents using sex- and puberty-specific homeostasis model assessment for insulin resistance (HOMA-IR) cutoffs.

Methods

This retrospective cross-sectional study included 207 obese patients (5-18 years old; 127 girls and 80 boys) assessed at a tertiary pediatric endocrinology clinic. IR was defined using sex-specific and pubertal stage-specific HOMA-IR thresholds. Anthropometric data and fasting glucose, insulin, lipid profile, glycated hemoglobin (HbA1c), and thyroid-stimulating hormone (TSH) were recorded. Receiver operating characteristic (ROC) analysis evaluated the TG/HDL-C ratio for IR discrimination.

Results

Compared with the IR-negative group, IR-positive participants had higher weight, body mass index (BMI) (and standard deviation score {SDS}), TG/HDL-C ratio, fasting insulin, HOMA-IR, HbA1c, fasting glucose, triglycerides, and TSH (all p<0.05). The best threshold for TG/HDL-C to identify IR was around 1.7 (area under the curve {AUC}=0.601; p=0.019), with sensitivity and specificity of 71.2% and 55.1%, respectively. Diagnostic accuracy was consistent across sex and pubertal groups.

Conclusions

The TG/HDL-C ratio demonstrates moderate diagnostic performance in detecting insulin resistance in obese children and adolescents, and this performance is independent of pubertal status or sex. In clinical settings, such as primary care, where insulin measurement and HOMA-IR calculation are not feasible, the TG/HDL-C ratio can be used as an independent marker. However, when insulin measurements are possible, this ratio should be considered a supportive marker alongside HOMA-IR. Additional investigations should assess the potential of this ratio to enhance diagnostic accuracy in multivariate analysis.

## Full-text entities

- **Genes:** POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, LIPC (lipase C, hepatic type) [NCBI Gene 3990] {aka HDLCQ12, HL, HTGL}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GK (glycerol kinase) [NCBI Gene 2710] {aka GK1, GKD}, insulin [NCBI Gene 100540225], LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CETP (cholesteryl ester transfer protein) [NCBI Gene 1071] {aka BPIFF, HDLCQ10}
- **Diseases:** thyroid dysfunction (MESH:D013959), type 2 diabetes (MESH:D003924), lipid disorders (MESH:D011017), glucose (MESH:D018149), hypertriglyceridemia (MESH:D015228), chronic systemic disease (MESH:D002908), atherogenic (MESH:D050197), elevated blood pressure (MESH:D006973), IR (MESH:D007333), Obese (MESH:D009765), overweight (MESH:D050177), Cushing's syndrome (MESH:D003480), genetic (MESH:D030342), metabolic disorders (MESH:D008659), Acanthosis nigricans (MESH:D000052), dyslipidemia (MESH:D050171)
- **Chemicals:** lipid (MESH:D008055), pyridoxal phosphate (MESH:D011732), glucose (MESH:D005947), HDL-C (-), T4 (MESH:D013974), TG (MESH:D013866), cholesterol esters (MESH:D002788), free fatty acids (MESH:D005230), cholesterol (MESH:D002784), 17-hydroxyprogesterone (MESH:D019326), cortisol (MESH:D006854), TG (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606], Meleagris gallopavo (common turkey, species) [taxon 9103]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967794/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12967794/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967794/full.md

---
Source: https://tomesphere.com/paper/PMC12967794